It’s the biomedical version of the classic Catch-22 conundrum. Early-career researchers often can’t obtain funding because they have no track record. But they can’t establish a track record without financial backing to get the research ball rolling.
Stepping into the breach for the past 18 years, the American Cancer Society has provided Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine, with internally competitive institutional research grants to support junior faculty members undertaking promising cancer research projects.
Supporting the Future of Medicine
Serving as a springboard to future achievements, the aim is to generate enticing, first-phase findings that allow budding investigators to compete for larger, external research grants from the National Institutes of Health and private philanthropic organizations.
“The American Cancer Society is proud to support future leaders in cancer research early in their careers,” said Joanne Elena, Ph.D., scientific director of the organization’s Clinical and Cancer Control Research Program. “Our longstanding collaboration with Sylvester propels innovative research that addresses the unacceptably high burden of cancer. The institutional research grants program helps identify the next generation of researchers to advance the American Cancer Society mission of ending cancer as we know it, for everyone.”
Joseph Rosenblatt, M.D., professor of medicine and microbiology and immunology at the Miller School, has been the program’s principal investigator since its launch at Sylvester in 2006
Full story: Kickstarting Cancer Research Pathways for Next-Gen Scientists – InventUM
